Publication | Closed Access

Bevacizumab improves the antitumor efficacy of adoptive cytokine-induced killer cells therapy in non-small cell lung cancer models

Cancer ImmunosurveillanceMedicineImmunologyAntitumor EfficacyBronchial NeoplasmImmune Checkpoint InhibitorCell TransplantationImmunotherapyOncologyCell BiologyLung Cancer